首页> 美国卫生研究院文献>ACS Medicinal Chemistry Letters >High Content Screening of Diverse Compound LibrariesIdentifies Potent Modulators of Tubulin Dynamics
【2h】

High Content Screening of Diverse Compound LibrariesIdentifies Potent Modulators of Tubulin Dynamics

机译:内容丰富的复合图书馆筛选识别微管蛋白动力学的有效调节剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tubulin modulating agents such as the taxanes are among the most effective antimitotic cancer drugs, although resistance and toxicity present significant problems in their clinical use. However, most tubulin modulators are derived from complex natural products, which can make modification of their structure to address these problems difficult. Here, we report the discovery of new antimitotic compounds with simple structures that can be rapidly synthesized, through the phenotypic screening of a diverse compound library for the induction of mitotic arrest. We first identified a compound, which induced mitotic arrest in human cells at submicromolar concentrations. Its simple structure enabled rapid exploration of activity, defining a biphenylacetamide moiety required for activity, A family of analogues was synthesized, yielding optimized compounds that caused mitotic arrest and cell death in the low nanomolar range, comparable to clinically used antimitotic agents. These compounds can be synthesized in 1–3 steps and good yields. We show that one such compound targets tubulin, partiallyinhibiting colchicine but not vinblastine binding, suggesting thatit acts allosterically to the known colchicine-binding site. Thus,our results exemplify the use of phenotypic screening to identifynovel antimitotic compounds from diverse chemical libraries and characterizea family of biphenylacetamides (biphenabulins) that show promise forfurther development.
机译:诸如紫杉烷的微管蛋白调节剂是最有效的抗有丝分裂性癌症药物,尽管耐药性和毒性在其临床使用中存在重大问题。然而,大多数微管蛋白调节剂衍生自复杂的天然产物,这可能使其结构改变以解决这些问题变得困难。在这里,我们报告发现新的具有简单结构的抗有丝分裂化合物,可以通过表型筛选各种化合物文库来诱导有丝分裂停滞而迅速合成。我们首先鉴定出一种化合物,该化合物可在亚微摩尔浓度下诱导人细胞中的有丝分裂停滞。其简单的结构使得能够快速探索活性,定义了活性所需的联苯乙酰胺部分。合成了一个类似物家族,产生了可导致有丝分裂阻滞和细胞死亡的优化化合物,其可与临床使用的抗有丝分裂剂媲美。这些化合物可以1-3个步骤合成,并且产率很高。我们证明了一种这样的化合物可部分靶向微管蛋白抑制秋水仙碱但不抑制长春碱结合,表明它对已知的秋水仙碱结合位点具有变构作用。从而,我们的结果例证了使用表型筛选来鉴定来自各种化学文库的新型抗有丝分裂化合物,并具有一个有前景的联苯乙酰胺(联苯菊酯)家族进一步的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号